Yinon Yoav, Beiner Mario E, Gotlieb Walter H, Korach Yaacov, Perri Tamar, Ben-Baruch Gilad
Division of Gynecological Oncology, Department of Obstetrics and Gynecology, The Chaim Sheba Medical Center, Tel-Hashomer, Tel-Aviv University, Israel.
Fertil Steril. 2007 Aug;88(2):479-84. doi: 10.1016/j.fertnstert.2006.11.128. Epub 2007 Apr 3.
To compare recurrence rates and fertility outcomes of patients with borderline ovarian tumors (BOTs) who underwent unilateral salpingo-oophorectomy with those of patients who underwent cystectomy only.
Retrospective study.
Gynecologic oncology department of a tertiary center.
PATIENT(S): Sixty-two patients with BOTs who underwent fertility-preserving surgery.
INTERVENTION(S): Unilateral salpingo-oophorectomy (USO, n = 40) or cystectomy only (n = 22).
MAIN OUTCOME MEASURE(S): Tumor recurrence rate, incidence of pregnancy.
RESULT(S): All 62 patients were alive with no clinical evidence of disease after a mean follow-up of 88 months. There was no statistically significant difference in mean tumor recurrence rates between patients who had undergone cystectomy only and those who had undergone USO (22.7% and 27.5%, respectively). In the cystectomy-treated group, the disease-free interval was shortened (23.6 compared with 41 mo), but the difference was not significant. However, the mean follow-up period for the cystectomy group was significantly shorter than for the USO group. Of the 62 patients, 25 (40.3%) attained 38 pregnancies, resulting in 35 deliveries.
CONCLUSION(S): Our results support previous findings that conservative surgery is an acceptable option for women with BOTs who wish to preserve fertility. Cystectomy, like oophorectomy, appears to be an adequate treatment, provided that the patient is willing to undergo careful and prolonged follow-up.
比较接受单侧输卵管卵巢切除术的卵巢交界性肿瘤(BOTs)患者与仅接受囊肿切除术的患者的复发率和生育结局。
回顾性研究。
某三级中心的妇科肿瘤科。
62例接受保留生育功能手术的BOTs患者。
单侧输卵管卵巢切除术(USO,n = 40)或仅行囊肿切除术(n = 22)。
肿瘤复发率、妊娠发生率。
62例患者均存活,平均随访88个月后无疾病临床证据。仅接受囊肿切除术的患者与接受USO的患者之间的平均肿瘤复发率无统计学显著差异(分别为22.7%和27.5%)。在囊肿切除术治疗组中,无病间期缩短(23.6个月对比41个月),但差异不显著。然而,囊肿切除术组的平均随访期显著短于USO组。62例患者中,25例(40.3%)成功妊娠38次,分娩35次。
我们的结果支持先前的研究结果,即对于希望保留生育功能的BOTs女性,保守手术是一种可接受的选择。囊肿切除术与卵巢切除术一样,似乎是一种充分的治疗方法,前提是患者愿意接受仔细且长期的随访。